More Than One in 10 With Cardiovascular Disease Face Food Insecurity
FRIDAY, Sept. 30, 2022 (HealthDay News) — Food insecurity increased from 1999 through 2018 among patients with cardiovascular disease (CVD), according to a study published online Sept. 28 in JAMA Cardiology.Eric J. Brandt, M.D., from the University o…
Learn MoreFDA Approves Dupixent for Prurigo Nodularis
FRIDAY, Sept. 30, 2022 (HealthDay News) — The U.S. Food and Drug Administration approved Dupixent (dupilumab) as the first treatment for adults with prurigo nodularis, according to Regeneron Pharmaceuticals.Prurigo nodularis, a chronic, debilitating …
Learn MoreFDA Approves Dupixent for Prurigo Nodularis
FRIDAY, Sept. 30, 2022 (HealthDay News) — The U.S. Food and Drug Administration approved Dupixent (dupilumab) as the first treatment for adults with prurigo nodularis, according to Regeneron Pharmaceuticals.Prurigo nodularis, a chronic, debilitating …
Learn MoreFDA Approves Dupixent for Prurigo Nodularis
FRIDAY, Sept. 30, 2022 (HealthDay News) — The U.S. Food and Drug Administration approved Dupixent (dupilumab) as the first treatment for adults with prurigo nodularis, according to Regeneron Pharmaceuticals.Prurigo nodularis, a chronic, debilitating …
Learn MoreFDA Approves New ALS Drug Despite Uncertain Data
FRIDAY, Sept. 30, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for amyotrophic lateral sclerosis (ALS). But approval of the drug, called Relyvrio (sodium phenylbutyrate/taurursodiol), is bo…
Learn MoreFDA Approves New ALS Drug Despite Uncertain Data
FRIDAY, Sept. 30, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for amyotrophic lateral sclerosis (ALS). But approval of the drug, called Relyvrio (sodium phenylbutyrate/taurursodiol), is bo…
Learn MoreFDA Approves New ALS Drug Despite Uncertain Data
FRIDAY, Sept. 30, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for amyotrophic lateral sclerosis (ALS). But approval of the drug, called Relyvrio (sodium phenylbutyrate/taurursodiol), is bo…
Learn MoreU.S. Will Spend $266 Million to Bolster Public Health Programs
FRIDAY, Sept. 30, 2022 (HealthDay News) — The U.S. government will invest $266 million to shore up the community and public health workforce using American Rescue Plan funding.About $225.5 million will go to 83 recipients to support training and appr…
Learn MoreU.S. Will Spend $266 Million to Bolster Public Health Programs
FRIDAY, Sept. 30, 2022 (HealthDay News) — The U.S. government will invest $266 million to shore up the community and public health workforce using American Rescue Plan funding.About $225.5 million will go to 83 recipients to support training and appr…
Learn MoreU.S. Will Spend $266 Million to Bolster Public Health Programs
FRIDAY, Sept. 30, 2022 (HealthDay News) — The U.S. government will invest $266 million to shore up the community and public health workforce using American Rescue Plan funding.About $225.5 million will go to 83 recipients to support training and appr…
Learn More